HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[22q11 deletion syndrome].

Abstract
22q11 deletion syndrome (formerly named CATCH22, DiGeorge, Velo-Cardio-Facial, Caylor, Kinouchi and Shprintzen syndrome) occurs in approximately 1/2000 to 4000 children. The genetic lesion is remarkably uniform, occurring mainly as 3 or 1.5 MB deletions in the 22q11.2 region. However, the clinical manifestations are variable and manifestation in several organ systems often occur. In this review we describe the various manifestations of the syndrome. Finally, we suggest strategies for diagnosing, evaluating and organizing the treatment for Danish patients with this syndrome.
AuthorsCharlotte Olesen, Peter Agergaard, Maria Boers, Stense Farholt, Carsten J Heilman, Lut Hvidkjaer, Kurt Kristensen, Marlene B Lauritsen, Jytte Lunding, Bent W Nielsen, Flemming Skovby, Nana Thrane, Ida Vogel, John R Østergaard
JournalUgeskrift for laeger (Ugeskr Laeger) Vol. 172 Issue 13 Pg. 1038-46 (Mar 29 2010) ISSN: 1603-6824 [Electronic] Denmark
Vernacular Title22q11-deletionssyndrom.
PMID20350479 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • DiGeorge Syndrome (diagnosis, genetics, therapy)
  • Humans
  • Infant
  • Infant, Newborn
  • Phenotype
  • Practice Guidelines as Topic
  • Terminology as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: